More on IRD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.08 |
|
|||
| Open | $3.08 | ||||
| 52 Wk High | $0.02 | ||||
| 52 Wk Low | $0.02 | ||||
| Day High | $3.29 | ||||
| Day Low | $3.08 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 269,795 | ||||
- Form 144 Opus Genetics, Inc. Filed by: Gagnon Robert E.
- Form 144 Opus Genetics, Inc. Filed by: Magrath George
- Form 144 Opus Genetics, Inc. Filed by: SCHACHLE JOSEPH K
- Form 144 Opus Genetics, Inc. Filed by: YERXA BENJAMIN R
- Opus Genetics (IRD) Reiterated at Overweight by Cantor Fitzgerald on Positive Update
- Opus Genetics sets September timeline for OPGx-BEST1 trial data
- Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
- BTIG on Opus Genetics (IRD): 'the path from here to BLA submission seems clear'
- B.Riley on Opus Genetics (IRD): 'we remain buyers'
- Opus Genetics gets FDA alignment on Phase 3 eye gene therapy trial
Entities mentioned with IRD
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- Show More...
